| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/02/2009 | EP1478233A4 Method for administering glp-1 molecules |
| 09/02/2009 | EP1457498B9 Novel peptide having angiotensin convertase inhibitory effect |
| 09/02/2009 | EP1456229B1 Method for preparing echinocandin derivatives |
| 09/02/2009 | EP1448587B1 Noonan syndrome gene |
| 09/02/2009 | EP1392349B1 Use of angiotensinogen and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/02/2009 | EP1364027B1 Zinc finger binding domains for nucleotide sequence ann |
| 09/02/2009 | EP1317479B1 Methods and compositions for diseases associated with amyloidosis |
| 09/02/2009 | EP1282443B1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 09/02/2009 | EP1262546B1 Novel scavenger receptors |
| 09/02/2009 | EP1091750B1 Cerebrospinal and vascular pharmaceutical composition and process for preparing the same |
| 09/02/2009 | EP1087991B1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 09/02/2009 | EP0892643B2 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 09/02/2009 | CN101522266A Topical skin compositions, their preparation, and their use |
| 09/02/2009 | CN101522265A Topical skin compositions, their preparation and their use |
| 09/02/2009 | CN101522207A Salicylanilides enhance oral delivery of therapeutic peptides |
| 09/02/2009 | CN101522206A Therapeutic and/or ameliorating agent for disseminated intravascular coagulation |
| 09/02/2009 | CN101519663A Recombinant CREG protein and application thereof |
| 09/02/2009 | CN101519658A Construction and expression of vector of tumstatin T7 of tumstatin T7 peptide and derivative T7-NGR thereof |
| 09/02/2009 | CN101519655A Abalone HINT gene and protein and application of same for preparing anticarcinogenic drug |
| 09/02/2009 | CN101519451A Recombinant human cytotoxic T lymphocyte associate antigen-4 fusion protein gene (sCTLA4-Ig) and pharmaceutical composition thereof |
| 09/02/2009 | CN101519445A Urine follicle-stimulating hormone with high specific activity and method for preparing same |
| 09/02/2009 | CN101519439A Freezeproof polypeptide, synthesis, composition containing same and application thereof |
| 09/02/2009 | CN101519438A Cyclic peptide compound in Hsisha sponge and application thereof |
| 09/02/2009 | CN101519437A Cyclic heptapeptide compound in Hsisha sponge and application thereof |
| 09/02/2009 | CN101519436A Cyclic octapeptide compound in Hsisha sponge and application thereof |
| 09/02/2009 | CN101519435A Cyclic nonapeptide compound in Hsisha sponge and application thereof |
| 09/02/2009 | CN101519427A Peptide derivative with endothelin receptor antagonizing activity, drug composition and application thereof |
| 09/02/2009 | CN101519426A Lactalbumin polypeptide with antioxidation activity and preparation method thereof |
| 09/02/2009 | CN101518651A Pastille slow-release material and preparation method and application thereof |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN101518647A Human papilloma virus preventative vaccine, construction method and application |
| 09/02/2009 | CN101518646A Lipase-containing composition |
| 09/02/2009 | CN101518645A Application of marine collagen peptide in preparing drugs, health care food or food for protecting renal function and delaying the process of chronic renal failure |
| 09/02/2009 | CN101518644A Application of Ang-2 and genes thereof in pharmacy |
| 09/02/2009 | CN101518471A Antibiotic artificial hip joint |
| 09/02/2009 | CN100535030C Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications |
| 09/02/2009 | CN100535013C Selective targeting of tumor vasculature using antibody molecules |
| 09/02/2009 | CN100534534C Method for improving oxygen transport by stored red blood cells |
| 09/02/2009 | CN100534528C Pharmaceutical combination of G-CSF and PLGF useful for blood stem cell |
| 09/02/2009 | CN100534527C Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GnRH |
| 09/02/2009 | CN100534436C Polynucleotide therapy |
| 09/02/2009 | CN100534419C Colloidal suspension of nanoparticles based on am amphiphilic copolymer |
| 09/01/2009 | US7584059 Inhibition of immune complex formation |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582733 Modified immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy |
| 09/01/2009 | US7582732 Lymphocyte antigen 6 complex, locus H (LY6H) protein for use in treatment and prevention of neurodegenerative diseases |
| 09/01/2009 | US7582728 Microwave-assisted peptide synthesis |
| 09/01/2009 | US7582727 Pharmaceutical formulations of bivalirudin and processes of making the same |
| 09/01/2009 | US7582726 cancer therapy utilizing novel vascular endothelial cell growth factor receptor antagonists; immunoglobulin like domain from kinase domain receptor; nucleic acid encoding prolactin receptor antagonizing domain, a VEGF ligand and a cytokine; cell based assay; |
| 09/01/2009 | US7582725 Agents, which inhibit apoptosis in cells that are involved in wound healing |
| 09/01/2009 | US7582670 methods of treating inflammatory-related diseases associated with pro-inflammatory cytokine expression and/or reduced expression of anti-inflammatory cytokines. The method typically comprises administration of one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof |
| 09/01/2009 | US7582610 Chimeric peptide: antagonist, endogeneous ligand binding to protein; therapy for metabolism disorders; obesity |
| 09/01/2009 | US7582609 Use of Peptide P144, an inhibitor of TGF- beta , for the treatment of skin fibrosis by its topical application; treats pathological scarring of the skin, fibrotic skin lesions; nongreasy, with good spreading characteristics |
| 09/01/2009 | US7582608 Amino acid sequences having C-terminal extensions or modifications, used as activators of G-protein coupled receptor kinases (VPAC2), for treating non-insulin-dependent or insulin-dependent diabetes; antidiabetic agents |
| 09/01/2009 | US7582607 Has genetically engineered disulfide bonds; reduced capacity of O-glycosylation when expressed in yeast compared to wild-type human FGF-21; vectors and host cells for propagation of nucleic acid sequences; non-insulin dependent diabetes, hypoglycemic agents; hyperinsulinemia, insulin resistance, obesity |
| 09/01/2009 | US7582606 Polypeptide includes an NADPH oxidase cytosolic cofactor polypeptide NOXA1 or p67phox having a C-terminal SH3 domain insertion mutation of at least three consecutive amino acids positioned so as to reduce activity of the purified polypeptide relative to the wild-type cofactor polypeptide |
| 09/01/2009 | US7582605 Phosphorus-containing hepatitis C serine protease inhibitors |
| 09/01/2009 | US7582604 Template-fixed peptidomimetics with antibacterial activity |
| 09/01/2009 | US7582603 Treatment of gastrointestinal inflammation by administering a peptide antagonist of tight junction opening that binds to the zonula occludens receptor, yet does not physiologically modulate the opening of mammalian tight junctions; celiac disease, inflammatory bowel disease |
| 09/01/2009 | US7582602 Hirulog-like peptide and gene therapy |
| 09/01/2009 | US7582601 Use of peptides derived from whey protein hydrolysate as active ingredients in a medicament or as food ingredient for elevating the cholescystokinin level in the blood, and for preventing or treatment of overweight and/or obesity, in an animal, including humans |
| 09/01/2009 | US7582478 Cleaved serum response factor in cardiac diagnosis and therapy |
| 09/01/2009 | US7582466 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid |
| 09/01/2009 | US7582461 Kit for detection, monitoring kinase, phosphatase; mixture of peptides; detectable compound; adjustment proteolytic sensitivity |
| 09/01/2009 | US7582451 Carotene synthase gene and uses therefor |
| 09/01/2009 | US7582450 Homogeneous preparations of IL-29 produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity |
| 09/01/2009 | US7582448 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 09/01/2009 | US7582442 Increasing biodegradation of glycerophospholipids in pulmonary surfactant by contacting a sample of pulmonary surfactant being a component of alveolar macrophage with a lysosomal phospholipase A2 (LPLA2) protein having an amino acid sequence of SEQ ID NO:2; phospholipid catabolism disorders; lungs |
| 09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
| 09/01/2009 | US7582439 Detecting the presence/absence of a complex of a Bim molecule (a novel member of the Bcl-2 family) and an antibody specific for a specific amino acid sequence;modulating physiological cell death or survival and/or modulating cell cycle entry; antiapoptosis; anticarcinogenic agents; autoimmune diseases |
| 09/01/2009 | US7582438 EphB receptor-binding peptides |
| 09/01/2009 | US7582437 Adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
| 09/01/2009 | US7582425 Identifying subjects who have or are at risk for developing Hereditary Spastic Paraplegia by detecting the presence or absence of one or more variations in the atlastin gene or treating HSP by administering atlastin |
| 09/01/2009 | US7582424 Genetic disorders and cholera endotoxins for calcium channel activators |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | US7582312 Surfactant composition prepared by lyophilization from an organic solvent; use in treating respiratory system disorders such as respiratory distress dysfunction, chronic obstructive pulmonary disease |
| 09/01/2009 | US7582311 Comprising hyaluronic acid or sodium hyaluronate dissolved in physiological buffer at concentration of 0.01-3 percent weight per volume and particles comprising first component biologically active agent and second component biocompatible polymeric matrix; use of 23-gauge or smaller bore needle |
| 09/01/2009 | US7582301 Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides |
| 09/01/2009 | US7582300 Modulation of gamma delta T cells to regulate airway hyperresponsiveness |
| 09/01/2009 | US7582296 Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof |
| 09/01/2009 | US7582291 A polypeptide of a bacteriophage lysin with a specific amino acid sequence; killing activity against enterococcal bacteria including both E. faecalis/faecium (including vancomycin resistant strains); bactericides; antibiotic resistance; nosocomial infections; rapid detection; grampositive bacteria |
| 09/01/2009 | US7582289 administering to proliferating cells in a mammal having a Ras-activated pathway a viruse selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus virus under conditions which result in lysis of neoplasmic cell |
| 09/01/2009 | US7582288 Methods of targeting multiple cytokines |
| 09/01/2009 | US7582287 Method for treating cervical cancer |
| 09/01/2009 | CA2308216C Use of non-immunosuppressive compounds for promoting nerve regeneration |
| 09/01/2009 | CA2283536C Compositions and methods for elimination of unwanted cells |
| 09/01/2009 | CA2274469C Serum-derived factor inducing cell differentiation and medical uses thereof |
| 09/01/2009 | CA2238360C Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 09/01/2009 | CA2210812C T-cell affecting peptides |
| 08/27/2009 | WO2009105786A2 Treatment for oral disease |
| 08/27/2009 | WO2009105783A1 Cosmetic and dermatological formulations of mntf peptides |
| 08/27/2009 | WO2009105780A2 Mntf peptide compositions and methods of use |
| 08/27/2009 | WO2009105629A2 Methods for the treatment and prevention of necrotizing enterocolitis |
| 08/27/2009 | WO2009105624A2 Simultaneous delivery of receptors and/or co-receptors for growth factor stability and activity |
| 08/27/2009 | WO2009105606A1 Compositions and methods for use of scar tissue in repair of weight bearing surfaces |
| 08/27/2009 | WO2009105557A1 Use of therapeutic peptides for the treatment and prevention of cancer |
| 08/27/2009 | WO2009105369A1 Sustained release poloxamer containing pharmaceutical compositions |
| 08/27/2009 | WO2009105284A1 Methods of preparation of macrocyclic compounds |
| 08/27/2009 | WO2009105231A1 Compositions and methods for treating vascular disorders |
| 08/27/2009 | WO2009105217A2 Complement inhibitors as therapeutic agents for treatment of cancer |